title: Is NICE ageist? Highlights from this issue.
authors.forename: Thomas
authors.initials: T
authors.lastname: Douglas
mesh_terms: D063506:Ageism; D020811:Biomedical Technology / Q000191:economics / Q000941:ethics; D003362:Cost-Benefit Analysis; D006077:Government Agencies / Q000941:ethics / Q000592:standards / Q000639:trends; D017048:Health Care Costs / Q000941:ethics; D015276:Health Care Rationing / Q000941:ethics; D006282:Health Personnel; D054625:Healthcare Disparities / Q000941:ethics; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage; D008017:Life Expectancy; D058873:Pandemics / Q000191:economics / Q000941:ethics / Q000517:prevention & control; D011788:Quality of Life; D019057:Quality-Adjusted Life Years; D006113:United Kingdom
chemical_list: D007252:Influenza Vaccines